Therapeutic effect of adalimumab in the treatment of intestinal Behçet's disease in children
ObjectiveIntestinal Behçet's disease is a rare but severe manifestation of Behçet's disease, particularly in pediatric populations. Currently, there is no cure for intestinal Behçet's disease, and the goal of treatment is to control acute episodes and reduce inflammation. Adalimumab, a tumor necrosi...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2025-06-01
|
| Sarja: | Frontiers in Pediatrics |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fped.2025.1619065/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|